COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE

被引：0
|
作者：
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Baynton, E. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2574
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS4
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [31] Disease characteristics in patients with and without psoriatic arthritis treated with etanercept
    Papp, K.
    Poulin, Y.
    Vieira, A.
    Shelton, J.
    Poulin-Costello, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (05) : 581 - 589
  • [32] Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
    Migliore, Alberto
    Bizzi, Emanuele
    Broccoli, Serena
    Lagana, Bruno
    CLINICAL RHEUMATOLOGY, 2012, 31 (01) : 133 - 137
  • [33] Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
    Alberto Migliore
    Emanuele Bizzi
    Serena Broccoli
    Bruno Laganà
    Clinical Rheumatology, 2012, 31 : 133 - 137
  • [34] Variations in treatment patterns, disease status and outcomes among patients with psoriatic arthritis receiving their first biologic in European union
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 54 - 54
  • [35] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Atteno, Mariangela
    Peluso, Rosario
    Costa, Luisa
    Padula, Stefania
    Iervolino, Salvatore
    Caso, Francesco
    Sanduzzi, Alessandro
    Lubrano, Ennio
    Del Puente, Antonio
    Scarpa, Raffaele
    CLINICAL RHEUMATOLOGY, 2010, 29 (04) : 399 - 403
  • [36] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Mariangela Atteno
    Rosario Peluso
    Luisa Costa
    Stefania Padula
    Salvatore Iervolino
    Francesco Caso
    Alessandro Sanduzzi
    Ennio Lubrano
    Antonio Del Puente
    Raffaele Scarpa
    Clinical Rheumatology, 2010, 29 : 399 - 403
  • [37] PATIENTS REPORTED OUTCOMES (PROS) IN PSORIATIC ARTHRITIS (PSA) WITH AXIAL INVOLVEMENT
    Vorobyova, Lyubov
    Korotaeva, Tatiana
    Loginov, Elena
    Korsakova, Yulia
    Gubar, Elena
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [38] Sustained improvement in functional status and vitality of psoriatic arthritis patients treated with etanercept
    Wanke, LA
    Mease, PJ
    Gottlieb, AB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A64 - A64
  • [39] Clinical remission in patients with psoriatic arthritis (PsA) treated with adalimumab (humira®). results of the stereo trial
    Van den Bosch, F.
    Manger, B.
    Goupille, P.
    McHugh, N.
    Kron, M.
    Kary, S.
    Kupper, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 743 - 743
  • [40] Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials
    Combe, Bernard
    Behrens, Frank
    McHugh, Neil
    Brock, Fiona
    Kerkmann, Urs
    Kola, Blerina
    Gallo, Gaia
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1063 - 1067
12345